acarix Press August 6, 2024 22 Sep 2022 Acarix presenterar på Redeye under temat Diagnostik Den 27 september kl 11.30 kommer Helen Ljungdahl Round, VD på Acarix, att presentera bolagets senaste utveckling inom Diagnostik Presen... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 22 Sep 2022 Acarix presents at the Redeye event, Theme: Diagnostics On September 27 at 11.30 am CEST, Helen Ljungdahl Round, President and CEO at Acarix will present the company´s latest developmen... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 22 Sep 2022 Acarix presenterar på Redeye under temat Diagnostik Den 27 september kl 11.30 kommer Helen Ljungdahl Round, VD på Acarix, att presentera bolagets senaste utveckling inom DiagnostikP... Continue reading
acarix News August 6, 2024 22 Sep 2022 Helen Ljungdahl Round, President and CEO presents at Redeye event, Theme: Diagnostics On September 27 at 9.00am CEST, Helen Ljungdahl Round, President and CEO at Acarix presented the company´s latest developments within d... Continue reading
acarix News August 6, 2024 06 Sep 2022 Highlights from the European Society of Cardiology Congress 2022 In the Special Session ‘Best of the European Heart Journal – Digital Health’ Simon Winther, MD, PhD, Gødstrup Hospital, Denmark was inv... Continue reading
acarix Press August 6, 2024 25 Aug 2022 Acarix AB (publ) publishes Interim Report, January – June 2022 Significant interest and positive developments in the US market We can now conclude that our Go-To-Market strategy in the USA has start... Continue reading
acarix Press August 6, 2024 25 Aug 2022 Acarix AB (publ) publicerar delårsrapport, januari – juni 2022 Stort intresse och positiv utveckling på den amerikanska marknaden Vi kan nu konstatera att vår Go-To-Market strategi i USA börjat gene... Continue reading
acarix English, Interim, IR, Listing Regulation, News, Q2, Regulatory, Report November 18, 2024 25 Aug 2022 Acarix AB (publ) publishes Interim Report, January – June 2022 Significant interest and positive developments in the US marketWe can now conclude that our Go-To-Market strategy in the USA has starte... Continue reading
acarix Interim, IR, Listing Regulation, News, Q2, Regulatory, Report, Swedish November 18, 2024 25 Aug 2022 Acarix AB (publ) publicerar delårsrapport, januari – juni 2022 Stort intresse och positiv utveckling på den amerikanska marknadenVi kan nu konstatera att vår Go-To-Market strategi i USA ... Continue reading
acarix Corporate Information, IR, News, Other Corporate Information, Swedish November 18, 2024 22 Aug 2022 Inbjudan till presentation av Acarix delårsrapport för andra kvartalet Acarix publicerar sin rapport för andra kvartalet torsdagen den 25 augusti 2022 kl 08.00. En direktsänd websändning h&ar... Continue reading
acarix Corporate Information, English, IR, News, Other Corporate Information November 18, 2024 22 Aug 2022 Invitation to presentation of Acarix´s second quarter report Acarix will publish its second quarter results on Thursday 25 August 2022 at 08.00 am (CEST). A live webcast will be held at 14.00 (CES... Continue reading
acarix Press August 6, 2024 22 Aug 2022 Inbjudan till presentation av Acarix delårsrapport för andra kvartalet Acarix publicerar sin rapport för andra kvartalet torsdagen den 25 augusti 2022 kl 08.00. En direktsänd websändning hålls kl 14.00 (CES... Continue reading